The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance

Kenneth H. Shain, Terry H Landowski, William S. Dalton

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

The influence of the microenvironment in the pathogenesis and progression of human cancer has traditionally been considered in the context of solid tumors. More recently, evidence has been accumulating to support the role of the bone marrow microenvironment in hematologic malignancies as well, particularly in multiple myeloma. This review focuses on myeloma as a model to demonstrate that the bone marrow microenvironment provides a sanctuary against programmed cell death and promotes tumor cell survival and progression. Additionally, the protective effects of the bone marrow milieu may confer a protection from cytotoxic drugs, allowing the emergence of drug-resistant tumors. These advances may assist in the design of novel therapeutic approaches to enhance the efficacy of standard chemotherapeutic drugs.

Original languageEnglish (US)
Pages (from-to)557-563
Number of pages7
JournalCurrent Opinion in Oncology
Volume12
Issue number6
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Tumor Microenvironment
Drug Resistance
Cell Survival
Bone Marrow
Neoplasms
Pharmaceutical Preparations
Hematologic Neoplasms
Multiple Myeloma
Cell Death
Therapeutics

ASJC Scopus subject areas

  • Cancer Research

Cite this

The tumor microenvironment as a determinant of cancer cell survival : A possible mechanism for de novo drug resistance. / Shain, Kenneth H.; Landowski, Terry H; Dalton, William S.

In: Current Opinion in Oncology, Vol. 12, No. 6, 2000, p. 557-563.

Research output: Contribution to journalArticle

@article{b1c84bf8d1ae47d29357acbe3260d87d,
title = "The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance",
abstract = "The influence of the microenvironment in the pathogenesis and progression of human cancer has traditionally been considered in the context of solid tumors. More recently, evidence has been accumulating to support the role of the bone marrow microenvironment in hematologic malignancies as well, particularly in multiple myeloma. This review focuses on myeloma as a model to demonstrate that the bone marrow microenvironment provides a sanctuary against programmed cell death and promotes tumor cell survival and progression. Additionally, the protective effects of the bone marrow milieu may confer a protection from cytotoxic drugs, allowing the emergence of drug-resistant tumors. These advances may assist in the design of novel therapeutic approaches to enhance the efficacy of standard chemotherapeutic drugs.",
author = "Shain, {Kenneth H.} and Landowski, {Terry H} and Dalton, {William S.}",
year = "2000",
doi = "10.1097/00001622-200011000-00008",
language = "English (US)",
volume = "12",
pages = "557--563",
journal = "Current Opinion in Oncology",
issn = "1040-8746",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - The tumor microenvironment as a determinant of cancer cell survival

T2 - A possible mechanism for de novo drug resistance

AU - Shain, Kenneth H.

AU - Landowski, Terry H

AU - Dalton, William S.

PY - 2000

Y1 - 2000

N2 - The influence of the microenvironment in the pathogenesis and progression of human cancer has traditionally been considered in the context of solid tumors. More recently, evidence has been accumulating to support the role of the bone marrow microenvironment in hematologic malignancies as well, particularly in multiple myeloma. This review focuses on myeloma as a model to demonstrate that the bone marrow microenvironment provides a sanctuary against programmed cell death and promotes tumor cell survival and progression. Additionally, the protective effects of the bone marrow milieu may confer a protection from cytotoxic drugs, allowing the emergence of drug-resistant tumors. These advances may assist in the design of novel therapeutic approaches to enhance the efficacy of standard chemotherapeutic drugs.

AB - The influence of the microenvironment in the pathogenesis and progression of human cancer has traditionally been considered in the context of solid tumors. More recently, evidence has been accumulating to support the role of the bone marrow microenvironment in hematologic malignancies as well, particularly in multiple myeloma. This review focuses on myeloma as a model to demonstrate that the bone marrow microenvironment provides a sanctuary against programmed cell death and promotes tumor cell survival and progression. Additionally, the protective effects of the bone marrow milieu may confer a protection from cytotoxic drugs, allowing the emergence of drug-resistant tumors. These advances may assist in the design of novel therapeutic approaches to enhance the efficacy of standard chemotherapeutic drugs.

UR - http://www.scopus.com/inward/record.url?scp=0034501628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034501628&partnerID=8YFLogxK

U2 - 10.1097/00001622-200011000-00008

DO - 10.1097/00001622-200011000-00008

M3 - Article

C2 - 11085455

AN - SCOPUS:0034501628

VL - 12

SP - 557

EP - 563

JO - Current Opinion in Oncology

JF - Current Opinion in Oncology

SN - 1040-8746

IS - 6

ER -